News

November 8, 2024
PRNewswire
Healthcare

Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today the submission of a New Drug Application (NDA) to the...

November 8, 2024
PRNewswire
Biotechnology

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma

Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced positive pre-clinical data on its anti-GPC3 in vivo chimeric antigen receptor...

November 8, 2024
PRNewswire
Networking

ITRI Joins Forces with EU 6G-SANDBOX for Advanced 6G R&D

At the 2024 EU-TW 6G SNS Joint Workshop in Taipei, the Industrial Technology Research Institute (ITRI), alongside its Taiwanese partners and the EU 6G-SANDBOX, presented the outcomes of their collaboration, showcasing...

November 7, 2024
Business Wire
Biotechnology

Murata’s Revolutionary Stretchable Printed Circuit Elevates Wearable Medical Devices

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) reveals an innovative new Stretchable Printed Circuit (SPC) technology marking a significant development in printed circuit technology. Murata’s SPC represents the...

November 7, 2024
Business Wire
Biotechnology

MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD

MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer through...

November 7, 2024
Business Wire
Artificial Intelligence

BearingPoint unveils Persona Engine: the platform brings customer data to life, providing a comprehensive understanding of customer needs, preferences, and behaviors

BearingPoint introduces Persona Engine, an advanced AI-driven platform in the area of customer intelligence, designed to transform how businesses understand and interact with their customers. By unlocking the full potential...

November 7, 2024
PRNewswire
Biotechnology

NAYO to Announce the Launch of Fully Automated Biobanking Solutions in Europe at Medica 2024

From 11 to 14 November, the 56th edition of MEDICA will take place in Düsseldorf, Germany. This year, MEDICA, one of the largest medical B2B trade fairs in the world, is...

November 7, 2024
PRNewswire
Biotechnology

Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders

Aditum Bio and Leads Biolabs today announced the formation of Oblenio Bio, which is being formed in conjunction with an exclusive option and license agreement to develop LBL-051, a...

November 7, 2024
Business Wire
Artificial Intelligence

CrowdStrike Launches AI Red Team Services to Secure AI Systems Against Emerging Threats

Fal.Con Europe – CrowdStrike (NASDAQ: CRWD) today launched CrowdStrike AI Red Team Services, reinforcing its leadership in protecting the infrastructure, systems and models driving the AI revolution. Leveraging CrowdStrike’s word-class threat intelligence...

November 7, 2024
PRNewswire
Joint Ventures

MGI Tech Partners with the Human Cell Atlas to Further Advance Worldwide Human Cell Mapping Efforts

MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced a commercial partnership with Human Cell Atlas (HCA)...